Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orchard Therapeutics (Sweden) AB
AB
Active
Org 5594038480
Stortorget 8, 211 34
Malmö
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2022
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Orchard Therapeutics (Sweden) AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
EM
Emma Maria Johanna Sjögren
Authorized Recipient of Service
Authorized Recipient of Service
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
FM
Fulvio Mavilio
Board of Directors
2022
HB
Hubert Baburaj Gaspar
Chairman
2022
FE
Frank Edward Thomas
Board of Directors
2022
Former (15)
JA
Jan Anders Fredrik Lovén
Deputy Board Member
2022 – 2023
JT
Jan Totte Dahlin
Deputy Board Member
2022 – 2023
VE
Viktor Elias Bergman Gullmark
Deputy Board Member
2022 – 2023
AH
Andreas Hans Eddie Ottosson
Deputy Board Member
2022 – 2023
AM
Anna Matilda Sjödin
Deputy Board Member
2022 – 2023
AC
Anna Camilla Biström
Deputy Board Member
2022 – 2023
LA
Lars Anders Larsson
Board of Directors
2022 – 2023
LM
Linn Mikaela Engman
Deputy Board Member
2022 – 2023
ES
Emelie Sofia Bergh
Deputy Board Member
2022 – 2023
AC
Anna Carolina Maria Bjarnhagen
Deputy Board Member
2022 – 2023
EA
Elin Anna Margareta Spjut
Deputy Board Member
2022 – 2023
EE
Eva Evelina Evelyn Sjöstedt
Deputy Board Member
2022 – 2023
MS
Mari Sinikka Kovaniemi Feldt
Deputy Board Member
2022 – 2023
OK
Olina Kristina Maria Wåhlstedt
Deputy Board Member
2022 – 2023
AK
Anna Klara Alina Bruksås Nybjörk
Deputy Board Member
2022 – 2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Orchard Therapeutics (Sweden) AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network